These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 21126692)
21. The spectrum of the symptoms and presentations of gastroesophageal reflux disease. Traube M Gastroenterol Clin North Am; 1990 Sep; 19(3):609-16. PubMed ID: 2228166 [TBL] [Abstract][Full Text] [Related]
30. Does laparoscopic antireflux surgery improve quality of life in patients whose gastro-oesophageal reflux disease is well controlled with medical therapy? Gillies RS; Stratford JM; Booth MI; Dehn TC Eur J Gastroenterol Hepatol; 2008 May; 20(5):430-5. PubMed ID: 18403945 [TBL] [Abstract][Full Text] [Related]
31. Clinical trial: the effects of the proton pump inhibitor dexlansoprazole MR on daytime and nighttime heartburn in patients with non-erosive reflux disease. Fass R; Chey WD; Zakko SF; Andhivarothai N; Palmer RN; Perez MC; Atkinson SN Aliment Pharmacol Ther; 2009 Jun; 29(12):1261-72. PubMed ID: 19392864 [TBL] [Abstract][Full Text] [Related]
33. Endoluminal gastroplication for the treatment of gastroesophageal reflux disease: a 2-year prospective pilot study from Taiwan. Liao CC; Lee CL; Lin BR; Bai CH; Hsieh YH; Wu CH; Gostout CJ J Gastroenterol Hepatol; 2008 Mar; 23(3):398-405. PubMed ID: 18318824 [TBL] [Abstract][Full Text] [Related]
34. GERD evaluation: time for a new paradigm? Modlin IM; Malfertheiner P; Hunt RH; Armstrong D; Holtmann G; Quigley EM; Spechler SJ J Clin Gastroenterol; 2007 Mar; 41(3):237-41. PubMed ID: 17426460 [TBL] [Abstract][Full Text] [Related]
35. The effect of an empirical trial of high-dose lansoprazole on symptom response of patients with non-cardiac chest pain--a randomized, double-blind, placebo-controlled, crossover trial. Bautista J; Fullerton H; Briseno M; Cui H; Fass R Aliment Pharmacol Ther; 2004 May; 19(10):1123-30. PubMed ID: 15142202 [TBL] [Abstract][Full Text] [Related]
36. Lower esophageal sphincter injections for the treatment of gastroesophageal reflux disease. Watson TJ; Peters JH Thorac Surg Clin; 2005 Aug; 15(3):405-15. PubMed ID: 16104131 [TBL] [Abstract][Full Text] [Related]
37. Effect of tegaserod on esophageal pain threshold, regurgitation, and symptom relief in patients with functional heartburn and mechanical sensitivity. Rodriguez-Stanley S; Zubaidi S; Proskin HM; Kralstein JR; Shetzline MA; Miner PB Clin Gastroenterol Hepatol; 2006 Apr; 4(4):442-50. PubMed ID: 16616348 [TBL] [Abstract][Full Text] [Related]
38. Belching: dyspepsia or gastroesophageal reflux disease? Lin M; Triadafilopoulos G Am J Gastroenterol; 2003 Oct; 98(10):2139-45. PubMed ID: 14572558 [TBL] [Abstract][Full Text] [Related]
39. Laboratory based investigations for diagnosing gastroesophageal reflux disease. Dolder M; Tutuian R Best Pract Res Clin Gastroenterol; 2010 Dec; 24(6):787-98. PubMed ID: 21126694 [TBL] [Abstract][Full Text] [Related]
40. Health-related quality of life and severity of symptoms in patients with Barrett's esophagus and gastroesophageal reflux disease patients without Barrett's esophagus. Eloubeidi MA; Provenzale D Am J Gastroenterol; 2000 Aug; 95(8):1881-7. PubMed ID: 10950030 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]